Latest filing published 20 Nov 2025 for Lexeo Therapeutics, Inc., €4,391.
Filing timeline
BuySaleInsider track record
Jenny Robertson: trading record in brief
This profile gathers the share dealings of Jenny Robertson in Lexeo Therapeutics, Inc. The record holds 10 filings, for trades running from 5 January 2024 to 18 November 2025.
Sales make up the whole of the open-market record (6 sales, €44k). The rest of the record consists of 4 share grants. 2025 to date brings no purchases and 6 sales.
The latest filing, published on 20 November 2025, reports an open-market sale of €4,391 in Lexeo Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jenny Robertson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 549 shares@ US$9.2714.4% of flowCommon StockSEC:0001995009-25-000005:0
- 9,900 shares0Common StockSEC:0001995009-25-000003:0
- 542 shares@ US$4.6687.1% of flowCommon StockSEC:0001415889-25-022477:0
- 521 shares@ US$2.7744.2% of flowCommon StockSEC:0001415889-25-013817:0
- 5,720 shares@ US$2.6145.1% of flowCommon StockSEC:0001415889-25-010503:0
- 2,101 shares@ US$4.41329.1% of flowCommon StockSEC:0001415889-25-005108:0
- 36,250 shares0Common StockSEC:0001415889-25-001285:0
- 23,750 shares0Common StockSEC:0000950170-24-003464:0
8 of 8 declarations
